no
Yes
Memantine is the chemical name for Namenda, a drug that treats moderate to severe Alzheimer's. Namenda or Memantine, is proven to improve behavior, thinking, and daily functioning in those suffering from Alzheimer's.
bun,creat, liver enzymes
I have heard some anecdotal reports of some doctors prescribing low dose namenda with vicodin to prevent or reverse opiod tolerance so it should be safe as long as the dose is kept low.
Namenda, or memantine, is primarily used to treat moderate to severe Alzheimer's disease. It works by regulating glutamate activity in the brain, which is involved in learning and memory. While it affects brain function, it is not classified as a psychotropic drug, which typically includes medications that alter mood, perception, or consciousness. Instead, Namenda is more focused on cognitive function rather than mood stabilization or psychosis treatment.
Whether a person with severe Alzheimer's should stop taking Namenda (memantine) should be determined by a healthcare professional. It is important to assess the individual's overall health, symptoms, and response to the medication. Namenda may help manage symptoms in some cases, even in advanced stages. Always consult with a doctor before making any changes to medication regimens.
Namenda (memantine) is primarily excreted by the kidneys, so its use can be affected by renal function. In patients with renal impairment, the medication's clearance may be reduced, which can lead to increased plasma levels and potential side effects. Therefore, dosage adjustments are often recommended for individuals with varying degrees of renal dysfunction to ensure safety and efficacy. Regular monitoring of renal function is advisable for patients taking Namenda.
Valium (diazepam) and Namenda (memantine) can be prescribed together, but it's important to do so under the guidance of a healthcare provider. Both medications can have sedative effects, so combining them may increase the risk of side effects like drowsiness or confusion. Always consult with a doctor or pharmacist before taking these medications together to ensure safety and proper management of any potential interactions.
In terms of Alzheimer's patients, a combination of Aricept and Namenda is the current best-evidence standard. Other products claiming to improve memory, as gingko and phosphatidylserine, do not have good documentation to support their claims.
The U.S. Food and Drug Administration (FDA) has approved two types of medications — cholinesterase inhibitors (Aricept®, Exelon®, Razadyne®) and memantine (Namenda®) — to treat the cognitive symptoms (memory loss, confusion, and problems with thinking and reasoning) of Alzheimer's disease.
Acetylcholinesterase inhibitors help to prevent the breakdown of acetylcholine, a neurotransmitter which functions suboptimally in dementia of the Alzheimer's type (Aricept and others). Also, NMDA receptor antagonists help to promote excitatory neurotransmitter function (Namenda).